These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25667097)

  • 1. The Health Impact Fund: how might it work for novel anticoagulants in atrial fibrillation?
    Banerjee A; Pogge T
    Glob Heart; 2014 Jun; 9(2):255-261.e2. PubMed ID: 25667097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk of thromboembolism in atrial fibrillation].
    Csanádi Z
    Orv Hetil; 2016 Sep; 157(38):1511-5. PubMed ID: 27640617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.
    Lang NN; Connelly DT
    J R Coll Physicians Edinb; 2013; 43(2):151-8. PubMed ID: 23734359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of atrial fibrillation burden in assessing thromboembolic risk.
    Zimetbaum P; Waks JW; Ellis ER; Glotzer TV; Passman RS
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1223-9. PubMed ID: 25516580
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of thromboembolic complication in atrial fibrillation by using anticoagulants.
    Wagh K; Vikhe VB; Kumar RS; Auti N; Jose M
    J Assoc Physicians India; 2013 Dec; 61(12):894-5. PubMed ID: 24968545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non valvular atrial fibrillation: the neurologist's perspective].
    Cunha L
    Rev Port Cardiol; 2012 Apr; 31 Suppl 1():27-31. PubMed ID: 22541032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time?
    Tzikas A; Freixa X; Ibrahim R
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1587-9. PubMed ID: 24215187
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC; Easton JD; Hankey GJ; Hart RG
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure. The forgotten factor in previous and recent studies regarding anticoagulation in atrial fibrillation.
    Kallistratos MS; Manolis AJ; Mancia G
    Int J Cardiol; 2013 Oct; 168(4):4434-5. PubMed ID: 23890867
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of thromboembolism in atrial fibrillation.
    Joglekar VK
    J Assoc Physicians India; 2013 Dec; 61(12):879-80. PubMed ID: 24968542
    [No Abstract]   [Full Text] [Related]  

  • 15. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
    Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation--rate versus rhythm control.
    Manning WJ
    N Engl J Med; 2003 Mar; 348(13):1284-6; author reply 1284-6. PubMed ID: 12661569
    [No Abstract]   [Full Text] [Related]  

  • 17. [ANMCO statement on prevention of thromboembolism in atrial fibrillation and role of the new oral anticoagulants].
    Colonna P; Abrignani MG; Colivicchi F; Verdecchia P; Alunni G; Bongo AS; Ceravolo R; Oliva F; Rakar S; Riccio C; Scherillo M; Valle R; Bovenzi F;
    G Ital Cardiol (Rome); 2013 Apr; 14(4):295-322. PubMed ID: 23567775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation in people with atrial fibrillation.
    Fang MC
    BMJ; 2011 Jan; 342():d530. PubMed ID: 21282259
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 20. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.